Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GI Outcomes of Myfortic vs CellCept in African American Kidney Transplant Recipients
NCT00522548Phase 4Terminated
- Sponsor
- University of Pennsylvania
- Start
- Mar 2007
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate sodium in kidney transplant rejection, sponsored by University of Pennsylvania. Started Mar 2007; status: terminated.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00522548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00522548.